|Discription||Vorasidenib, also known as AG-881, is a potent and selective orally available inhibitor of mutated forms of both isocitrate dehydrogenase type 1 (IDH1, IDH1 [NADP+] soluble) in the cytoplasm and type 2 (IDH2, isocitrate dehydrogenase [NADP+], mitochondrial) in the mitochondria, with potential antineoplastic activity.|
|Synonyms||AG-881, AG 881, AG881|
Store lyophilized at -20ºC, keep desiccated.
|In vitro||DMSO||75 mg/mL (180.83 mM)|
|Ethanol||75 mg/mL (180.83 mM)|
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.1 mM||24.11 mL||120.56 mL||241.11 mL|
|0.5 mM||4.82 mL||24.11 mL||48.22 mL|
|1 mM||2.41 mL||12.06 mL||24.11 mL|
|5 mM||0.48 mL||2.41 mL||4.82 mL|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2